---
title: PharmaLegacy Laboratories vs Reaction Biology
slug_a: pharmalegacy
slug_b: reactionbiology
site: cro
review_signal_gate: closed
canonical_path: /compare/pharmalegacy/reactionbiology
generated_by: BioBM Editorial AI
---

# PharmaLegacy Laboratories vs Reaction Biology

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

PharmaLegacy Laboratories (pharmalegacy) is listed for cro. Preclinical CRO with over 1,500 validated in vivo efficacy models spanning 100+ indications in oncology, immunology, inflammation, and bone disease. AAALAC-accredited vivarium with capacity for 30,000 rodents and 350 non-human primates supports IND filings to FDA and CFDA.

Services: 8. Modalities: 2. Indications: 3. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (8).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Reaction Biology (reactionbiology) is listed for cro. Global preclinical CRO specializing in kinase drug discovery, cell-based assays, in vivo pharmacology, and immuno-oncology with 1,000+ cell lines and hundreds of validated protein targets across US and EU facilities.

Services: 19. Modalities: 5. Indications: 3. Locations: 7. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (19).

Review summary: Review summary withheld until site-level review gate opens.